Dr. Peter Schueler, Senior VP Drug Development Services, Neurosciences at ICON, talks about topics discussed in a timely new book he edited titled Innovation in Clinical Trial Methodologies.
Editorial Podcasts
Advertisement
John Reites, CEO of THREAD Research, discusses how his organization is adapting to decentralized trials and efforts they're taking to increase patient recruitment.
Advertisement
Dr. Theodore Leng, MD, Medical Advisor to Verana Health and Director of Clinical and Translational Research at the Byers Eye Institute at Stanford, Stanford University Medical School, talks about a recent study he led and presented in early May at the Association for Research in Vision and Ophthalmology Meeting.
Courtney Granville, Global Associate Director, Research and Scientific Programs at DIA, talks about the options decentralized trials provide, the options that DIA is offering its members to learn in a hybrid environment, and the options healthcare and research should provide for patients now.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5